H
MRK icon

HoyleCohen’s Merck MRK Stock Holding History

HoyleCohen’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$14M Sell
113,173
-836
-0.7% -$108K 1.06% 27
2024
Q1 		$15M Buy
114,009
+513
+0.5% +$63.2K 1.15% 23
2023
Q4 		$12.4M Buy
113,496
+1,774
+2% +$184K 1.01% 27
2023
Q3 		$11.5M Sell
111,722
-864
-0.8% -$93.1K 1.07% 24
2023
Q2 		$13M Sell
112,586
-1,233
-1% -$140K 1.15% 22
2023
Q1 		$12.1M Sell
113,819
-1,520
-1% -$164K 1.13% 22
2022
Q4 		$12.8M Sell
115,339
-958
-0.8% -$97.9K 1.27% 19
2022
Q3 		$10M Buy
116,297
+195
+0.2% +$17.4K 1.1% 23
2022
Q2 		$10.6M Sell
116,102
-3,546
-3% -$314K 1.1% 24
2022
Q1 		$9.82M Buy
119,648
+2,447
+2% +$193K 0.84% 29
2021
Q4 		$8.98M Buy
117,201
+4,042
+4% +$322K 0.75% 33
2021
Q3 		$8.5M Buy
113,159
+1,109
+1% +$84.3K 0.81% 33
2021
Q2 		$8.71K Sell
112,050
-4,924
-4% -$366K 0.68% 33
2021
Q1 		$8.6M Sell
116,974
-620
-0.5% -$45.7K 0.87% 28
2020
Q4 		$9.18M Buy
117,594
+66,114
+128% +$5.06M 1.06% 23
2020
Q3 		$4.08M Buy
51,480
+826
+2% +$64.7K 0.6% 47
2020
Q2 		$3.74M Buy
50,654
+238
+0.5% +$17.9K 0.63% 47
2020
Q1 		$3.7M Buy
50,416
+4,240
+9% +$333K 0.74% 38
2019
Q4 		$4.01M Buy
46,176
+341
+0.7% +$28K 0.64% 48
2019
Q3 		$3.68M Buy
45,835
+212
+0.5% +$17K 0.63% 46
2019
Q2 		$3.65M Buy
45,623
+1,656
+4% +$127K 0.63% 46
2019
Q1 		$3.49M Buy
43,967
+6,740
+18% +$504K 0.62% 50
2018
Q4 		$2.71M Buy
37,227
+1,819
+5% +$128K 0.55% 53
2018
Q3 		$2.4M Buy
35,408
+729
+2% +$46.4K 0.45% 58
2018
Q2 		$2.01M Buy
34,679
+2,426
+8% +$137K 0.41% 60
2018
Q1 		$1.68M Buy
32,253
+5,460
+20% +$295K 0.34% 69
2017
Q4 		$1.44M Buy
+26,793
New +$1.49M 0.28% 76

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HoyleCohen's MRK Position: Q2 2024 in Review

HoyleCohen reduced its Merck (MRK) stake by 0.73% in Q2 2024, selling an estimated $108K and leaving 113,173 shares worth $14M. The position accounts for 1.06% of the portfolio, ranked #27.

HoyleCohen first reported a position in MRK in Q4 2017 and has held it in 27 quarters since. The position peaked at $15M in Q1 2024. 3,544 funds tracked by Wall St. Rank hold MRK as of Q2 2024.

  • HoyleCohen held 113,173 shares of Merck worth $14M as of Q2 2024.
  • HoyleCohen sold 836 Merck shares in Q2 2024, an estimated $108K.
  • Merck made up 1.06% of HoyleCohen's portfolio in Q2 2024, its #27 holding.
  • HoyleCohen first reported a position in Merck in Q4 2017 and has held it in 27 quarters since.
  • HoyleCohen's Merck position peaked at $15M in Q1 2024.
  • 3,544 funds tracked by Wall St. Rank held Merck as of Q2 2024.

Based on HoyleCohen's 13F filing for Q2 2024, filed 19 Jul 2024.